Semua Kategori
| Product Name | Deskripsi | Action |
|---|---|---|
| Cetuximab,Erbitux,EGFR,IMC-C225,Anti-EGFR monoclonal antibodi,Chimeric IgG1 antibodi,Oncology biologic / Colorectal cancer antibodi / Head and neck cancer antibodi,CAS No.205923-56-4 | Trade Name : Erbitux Target : EGFR Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 650(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Aflibercept, Eylea, VEGF/PlGF, Zaltrap, VEGF-Trap, Agen Anti-VEGF / Inhibitor VEGF, VEGF Trap / VEGF Decoy Receptor, Agen Antiangiogenik, Fusion Protein, CAS No. 862111-32-8 | Trade Name : Eylea Target : VEGF/PlGF Molecular Type : Fusion Protein Sales in 2025 (Millions of USD) : 7770(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Trastuzumab Emtansine | Trade Name : Kadcyla Target : Her2 Molecular Type : ADC Sales in 2025 (Millions of USD) : 2000~2200(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Trastuzumab Deruxtecan | Trade Name : Enhertu Target : Her2 Molecular Type : ADC Sales in 2025 (Millions of USD) : 4500~5000(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Trastuzumab,Herceptin,Her2,HER2-targeted therapy,Anti-HER2 monoklonal antibody,Oncology biological / Breast cancer antibody,Monoklonal antibody for HER2-overexpressing tumors,CAS No. 180288-69-1 | Trade Name : Herceptin Target : Her2 Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 3000 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Nivolumab dan berahyaluronidase alfa-pmph ,Opdivo SC ,Suntikan Subkutan Opdivo ,Opdivo Qvantig ,BMS-986251 ,Inhibitor PD-1 Subkutan ,Produk Kombinasi (901 dan 932) | Trade Name : Opdivo Qvantig® Target : N/A Molecular Type : Combination Product (901 and 932) Sales in 2025 (Millions of USD) : N/A All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Nivolumab dan relatlimab-rmbw ,Suntikan Opdualag ,PD-1, LAG-3 ,BMS-986213 ,Inhibitor ganda PD-1 / LAG-3 ,Imunoterapi kombinasi dosis tetap ,Kombinasi Dosis Tetap (902 dan 962) | Trade Name : Opdualag Target : PD-1, LAG-3 Molecular Type : Fixed-dose Combination (902 and 962) Sales in 2025 (Millions of USD) : 1000~1200(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get ... |
|
| Nivolumab | Trade Name : Opdivo Target : PD-1 Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 12000 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
